The anti-obesity effect of TPEE is likely due to reduced expression of lipogenic genes such as FAS, SREBP-1c, PPARγ and leptin and up regulation of adiponectin and AMPK-1α. The gene discussed is SREBF1; the disease is obesity due to melanocortin 4 receptor deficiency.